Medical device antitrust wins are not enough for hospitals

Two recent federal jury verdicts found major medical device manufacturers Biosense Webster and Medtronic guilty of anticompetitive practices that harmed hospitals by tying essential services and discounts to their own products, blocking cost-saving alternatives. These rulings awarded substantial damages and signal increased judicial intolerance for monopolistic conduct in the US medical device market.

This Wire brief sits within Fusion42's coverage of Medtech.